{"organizations": [], "uuid": "db677fe4f2ced8d86ef423c0afbc20bdf6046345", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-protein-science-to-advance-through/brief-protein-science-to-advance-through-leniobio-and-dow-agrosciences-license-agreement-idUSASO000211", "country": "US", "domain_rank": 408, "title": "BRIEF-Protein Science To Advance Through Leniobio And Dow Agrosciences License Agreement", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-15T14:40:00.000+02:00", "replies_count": 0, "uuid": "db677fe4f2ced8d86ef423c0afbc20bdf6046345"}, "author": "", "url": "https://www.reuters.com/article/brief-protein-science-to-advance-through/brief-protein-science-to-advance-through-leniobio-and-dow-agrosciences-license-agreement-idUSASO000211", "ord_in_thread": 0, "title": "BRIEF-Protein Science To Advance Through Leniobio And Dow Agrosciences License Agreement", "locations": [], "entities": {"persons": [{"name": "leniobio", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "dowdupont inc", "sentiment": "none"}, {"name": "dow agrosciences license agreement reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 15, 2018 / 12:40 PM / Updated an hour ago BRIEF-Protein Science To Advance Through Leniobio And Dow Agrosciences License Agreement Reuters Staff March 15 (Reuters) - DowDuPont Inc: * PROTEIN SCIENCE TO ADVANCE THROUGH LENIOBIO AND DOW AGROSCIENCES LICENSE AGREEMENT * LENIOBIO - EXCLUSIVE LICENSE TO ENABLE LENIOBIO TO UTILIZE DOW AGROSCIENCES’ PROPRIETARY EUKARYOTIC CELL-FREE PROTEIN EXPRESSION TECHNOLOGY​ * ‍LENIOBIO - WILL MARKET INNOVATION TO BIOPHARMACEUTICAL DEVELOPERS UNDER BRAND NAME ALICE​ * LENIOBIO - WILL LAUNCH ALICE PLATFORM IN 2018 INITIALLY AS AN EXPRESSION KIT THAT YIELDS HIGHER AMOUNTS OF PROTEINS ON AVERAGE Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-15T14:40:00.000+02:00", "crawled": "2018-03-15T15:01:45.011+02:00", "highlightTitle": ""}